chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started to have symptoms 12/13 and they were just sore throat and cough. My husband was at home and positive, so I knew it probably came home from him. I tested for COVID-19 home test and I was negative which prompted me to get a PCR test. The results came back on 12/15 and were positive for COVID-19. I called the doctor and did a telehealth, and I was prescribed PAXLOVID. I never felt really bad and never got anything worse than a sore throat. On 12/22 I started getting really sick and I took another home test and it was positive. I took another test this morning and it was positive as well and I feel really sick. I have also noticed my blood oxygen via smart watch is very low. I don't think this is related to the vaccine.
Began with inflammation at injection site that then spread to neck. Patient's ability to swallow and move neck gradually worsened to the point where they can no longer move head/neck or swallow and impeding speech. It has been 5 days and patient reports that condition is still worsening. Went to urgent care clinic today.
Difficulty breathing, throat closing, high fever, stuffy sinuses, nauseous. Pt given BENADRYL to stop reaction & observed.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPERCAPNIC RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXEMIA 3/16/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
tingling in my hands, my face and my feet/  started like in chin area and spread; Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in my hands, my face and my feet/  started like in chin area and spread), CHILLS (Chills) and MYALGIA (Body aches) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Sep-2021, the patient experienced CHILLS (Chills) and MYALGIA (Body aches). On 16-Sep-2021, the patient experienced PARAESTHESIA (tingling in my hands, my face and my feet/ started like in chin area and spread). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 12-Sep-2021, CHILLS (Chills) and MYALGIA (Body aches) had resolved. At the time of the report, PARAESTHESIA (tingling in my hands, my face and my feet/ started like in chin area and spread) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported
The day after vaccination, I had a fever of 100F from the time I woke up to the time I went to sleep. No treatment given. The next day, I woke up and my temperature was back to normal.
Pain at injection site, headache, muscle aching, all joints aching, fever, felt like hit by a truck started 11 pm at night. Woke up 5 am 2/19/19  with severe headache, fever, aching  took 2 advil and  had sweats and by 2 pm 2/19/19 finally symptoms had resolved.
Pt noticed redness, swelling, tenderness at site of vaccine approx. 24 hours after receiving. Pt had slight itching at site, redness approx. 2" across.
Client into HO C/T a cat scratch to lip, TD 10 yrs, given 3/21/06 IM Left arm, 4/3/06 client called me ant stated she felt she had had a reaction 1 week after shot with itching, at site, some swelling, soreness continues no rabies in animal.  She went to MD for treatment to lip. 4/18/06 states left breast mastoiditis with antibiotics, a biopsy is planned. Soreness on top her arm remains (mammogram done between 3/21 and 4/3). Sore just below left elbow. Told not to have another TD and for me to file a report.
1 wk. after pt. received vaccine she started c/o feeling tired.  Pt had several weeks of fatigue symptoms that continued until Feb. 2008.  Several different laboratory evaluations were performed and nothing could be related to pts. symptoms.  Mom saw a television talk where another female child had similar problems.  So mom wanted this reported.  Mom is also a nurse and is concerned the vaccine may have been the reason for fatigue s/s for so long.
Released from ER after receiving 2nd Pfizer vaccine. 1 mile down the road, I could no longer drive.  I had to pull over on the highway.  I had a tingling in my face, immediately followed by a combination of severe headache, hard to breath, rapid heartbeat and feeling like I was going to pass out.  I wasn't able to even dial my phone.  A construction worker on the side of the highway called for the ambulance and I was transported back to the ER.
8-14-09 Ball of left foot extremely sore, painful and remained sore, red painful as of 8-17-09 but improving
Swollen left arm 2 1/2 times the size of other arm, red and hot to touch.
swollen arm; Soreness; severe chills; severe shakes; high blood pressure; fever of 100.9 F; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (severe chills), TREMOR (severe shakes), HYPERTENSION (high blood pressure), PYREXIA (fever of 100.9 F) and PERIPHERAL SWELLING (swollen arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced CHILLS (severe chills), TREMOR (severe shakes), HYPERTENSION (high blood pressure) and PYREXIA (fever of 100.9 F). On 04-Mar-2021, the patient experienced PERIPHERAL SWELLING (swollen arm) and PAIN (Soreness). On 04-Mar-2021, CHILLS (severe chills), TREMOR (severe shakes), HYPERTENSION (high blood pressure) and PYREXIA (fever of 100.9 F) had resolved. At the time of the report, PERIPHERAL SWELLING (swollen arm) and PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Site of injection for DTAP was red, warm to touch and swollen. Pt complained of itching at site.
Rapid heart rate.  Went to personal doctor Feb 24, 2021.  Echocardiogram March 9, 2021.  Heart Ablation prescribed and executed October 2022 for SVT.
patient was underage when she received covid19 moderna vaccine. patients parents approved for her to get dose 2.
Patient received Moderna updated Covid-19 vaccine on 9/21/2023. Patient developed Flu like symptoms on 9/26/2023. Patient developed progressive headache, dizziness, tinnitus, decreased hearing, confusion, was admitted on 10/14/2023 . Patient was diagnosed with Varicella Zoster Meningitis.  Patient developed Non sustained Ventricular Tachycardia on 10/19/23.  Patient was started on Acyclovir 800 mg IV every 8 hour on 10/15/2023 and is planned until 11/06/2023.  Patient received Solu-Medrol 1 g IV QD x 3 days. Neurology considered IVIG but was not ordered.
Patient was administer 0.3 mL of undiluted Pfizer Vaccine.  Pt. offered MD exam to include EKG and troponin levels with follow up.  Pt has no complains.
No adverse effect reported; expired dose of VAQTA was administered; This spontaneous report was received from a medical assistant refers to a patient of unknown age. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 30-SEP-2019 the patient was vaccinated with  expired dose of hepatitis a vaccine, inactivated(VAQTA) (lot # R027431, expiry date: 08-SEP-2019, route and anatomical location were not reported) for prophylaxis (expired product administered). No adverse effect reported. No additional information provided.
It was discovered after administration of the shot that several syringes had only 0.1ml instead of 0.5ml.  This left us uncertain what volume he had received.  We were able to bring the patient back in round 2 hours later and administered another 0.4ml in the other arm.  Over the next few days, he had routine post-shot side effects (sore arms x 2, fatigue) but was otherwise well.
Experienced some side effects after second shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Experienced some side effects after second shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION COMPLICATION (Experienced some side effects after second shot). At the time of the report, VACCINATION COMPLICATION (Experienced some side effects after second shot) outcome was unknown.            No concomitant product use was provided by the reporter.   No treatment medications were reported.
Fever; Joint pain; Muscle pain; Chills; This is a spontaneous report from a contactable consumer. A 72-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL9261), via an unspecified route of administration, administered in arm on an unspecified date as dose number unknown, single for covid-19 immunisation. Medical history none and concomitant medications were not reported.  On an unspecified date, she was calling about the shot Saturday morning 10 am. She confirmed it was the Pfizer COVID 19 vaccine. She stated that she doesn't have any other reason to all. She had some joint pain, fever and muscle pain and she got at 10 o'clock Saturday (on an unkown date) and she also has chills. She asked is that normal are they going to tell normal how do she is woman not many patients. She does not know how much they gave she only knows that they stuck her in the arm. She said that nothing else to add. There was nothing until today. She confirmed she means that the symptoms started today. Outcome of the event was unknown.    Follow-up (12May2021): Follow-up attempts completed. No further information expected.
vaccine was administered on 1/20/22. the vaccine expired on 1/19/22.  There was no temperature excursion.
Information has been received from a nurse practitioner concerning a 14 year old female who on 17-NOV-2007 was vaccinated with Gardasil and has had injection site pain since then.  Onset of injection site pain was also reported as 13-JAN-2007.  Medical attention was sought, patient called nurse practitioner.  Additional information has been requested.
generalized sz w/in 1s 24 hrs p/vax; t>101;
within 2 hours of the shot I had nausea, vomiting and diarrhea the following day about 1pm(24 hours after the shot) I had severe lower back pain, it felt like kidney stones which I have had in the past.
pt. received covid immunization on 5/8/21.  On 5/16/21 patient has reddened circle, slightly warm to touch.  Noticed about 4pm.  Advised patient this is a common reaction, to keep track of it, if worsens to be seen, take ibuprofen.  Patient felt fine.
This case was reported by a pharmacist via sales rep and described the occurrence of injection site reaction in unspecified number of patients who received FLULAVAL QUADRIVALENT. On an unknown date, the patient received FLULAVAL QUADRIVALENT (intramuscular) .5 ml. On an unknown date, an unknown time after receiving FLULAVAL QUADRIVALENT, the patients experienced injection site reaction. On an unknown date, the outcome of the injection site reaction was unknown. The reporter considered the injection site reaction to be almost certainly related to FLULAVAL QUADRIVALENT. Additional details provided were as follows: This case was reported by a hospital pharmacist via GlaxoSmithKline employee (sales rep). The reporter stated that approximately 10 patients experienced various injection site reactions after receiving FLULAVAL QUADRIVALENT. The pharmacist reported that several patients needed to be treated at the emergency room. The pharmacist did not report any quality issue, just basically was saying that he had seen more reactions this year. The pharmacist told the field rep that he had contacted the FDA Med Watch system to file this adverse event as well.
Information had been received on 11-JUL-2016 from a medical assistant who reported that an improperly stored dose of VARIVAX (dose/frequency not reported) (lot # L019124, expiration date 27-MAY-2017) was administered to a patient (age and gender not reported) subcutaneously on an unspecified date. No adverse experience reported. No further information was provided. Additional information has been requested.
Information has been received from a 66 year old female with arthritis and no drug allergies who on 05-NOV-2008 was vaccinated with ZOSTAVAX (Merck) 0.65ml, (lot # not provided).  Concomitant therapy included MOBIC.  A few days after vaccination, on 07-NOV-2008 the patient experienced a headache.  "Routine labs" tests were performed (results not provided).  The patient's headache persisted.  The patient sought unspecified medical attention.  Additional information has been requested.
The muscle of my right arm is damaged by some internal way causing it to become frozen. I now needed a pin point injection and will need physical therapy. The doctor suggested there may have been a bleed within. ( I thought it was a torn rotator cuff, but negative MRI )
my arm was swollen; big rash on my arm; This case was reported by a consumer via other manufacturer and described the occurrence of swelling arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced swelling arm and rash. On an unknown date, the outcome of the swelling arm and rash were unknown.   It was unknown if the reporter considered the swelling arm and rash to be related to Shingrix.  Additional details were reported as follows: This case was reported by patient herself. The age at vaccination was not reported. 3 years ago, or so, the patient received 1st dose of Shingrix and experienced a big rash on my arm and was swollen. The physician said it was not a normal response and after that doctor told her to do not take the 2nd shot. The patient stated that she did not like that physician very much, so she called somebody, a nurse practitioner who gives vaccines for when you travel and the nurse advised her to take an ibuprofen and Benadryl before vaccinations.  The reporter's and healthcare professional s consent to follow-up was reported as not applicable.
Case number PHEH2015US026938, is an initial spontaneous report received from a nurse on 22 Dec 2015. This report refers to a 25 years old male patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1514501, expiry date: May 2016) into left deltoid on 07 Oct 2015. It was reported that before administration the FLUVIRIN had a temperature excursion of 34 degrees. The reporter stated that she did not know why the refrigerator was out of temperature range for an unspecified amount of time overnight. She checked the temperature before she left for the day and when she arrived the next day and the temperature was fine. It was a new refrigerator and there have not been any problems since the temperature excursion. No adverse reaction was experienced by the patient following the maladministration. No further information provided. Follow up information received from the nurse on 26 Jan 2016: Reporter's comment updated.
Large, hard, warm, red, raised oval, painful area 1" x 1/2", on left leg where varicella was given. Occurred slowly over several days (1 week).
It felt like they were injecting razor blades into my arm. Immediately after injection, I experienced heart palpitations and a racing heartbeat, and got lightheaded/dizzy.
Information has been received from a licensed practical nurse concerning a multiple unspecified patients of unknown ages and genders. The patients' pertinent medical history, drug reactions/allergies and concurrent conditions were not informed. On an unknown dates, the patients administered improperly stored doses of VARIVAX lot # M012992, expiration date 14-MAR-2018, (dosages and therapy routes were not provided). Concomitant therapies were not informed. The doses of VARIVAX were exposed to a temperature of 21.3C and were out of range for 1 hour. A data logger was used to track the temperature and there were no prior excursions. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested. This is one of several reports from the same source.
redness, pain and tenderness at the injection site; redness, pain and tenderness at the injection site; flare; This is a spontaneous report from a contactable nurse via a Pfizer Sales Representative. This nurse reported similar events for three patients (nurse's mother and two patients in the office). This is the third of three reports.  A male patient of an unspecified age received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13, unknown lot number and expiration date), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced redness, pain and tenderness at the injection site. The patient also experienced flare on unspecified date. Outcome of the events was unknown.   Information on the batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2019296476 different patient, same drug and event;US-PFIZER INC-2019296429 different patient, same drug and event;US-PFIZER INC-2019296429 different patient, same drug and event
Pt noticed a dent at injection site with skin discoloration, went to ER and was told that the muscle had collapsed.
The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023).    No concomitant medication was reported.  Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case was reported for patient 22 out of 50 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)
Had flu inject OCT90 around thanksgiving weakness of lower extremities; unable to ambulate-hospitalized x 10 days; dx demyeletory nerve disease;
Post vax, the pt developed left testicular swelling and mild erythema of left hemiscrotum with generalized tenderness. He also walks with legs slightly abducted. Dx with orchitis and treated with ibuprofen.
Approximately 45 minutes after receiving vaccines pt started with muscle tightness in his neck and shoulders then a severe headache with light sensitivity and vomiting, then the chills, and a slight fever (max temp 100.1 orally). Symptoms lasted 12 hrs.
"pt recv vax 25JUL96 & 26JUL96 pt exp diff & pain when walking, & the  inj site was hard;to ER;"
Numbness in right arm. Intermittent. Started noticing after initial vaccine soreness went away. Persistent. Undergoing physical therapy.
Itchiness on hands; Muscle aches (mostly hips and legs); Worsening eczema; Trunk rash (around 30 itchy red spots); Trunk rash (around 30 itchy red spots); Petechiae on shins; This is a spontaneous report from a contactable consumer (patient herself). A 34-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EW0168 and expiration date was not reported), via an unspecified route of administration in left arm on 11May2021 10:30 as 1st dose, single (age at vaccination was 34-year-old) for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient medical history included ongoing Eczema, Raynaud's, ANA-positive. The patient concomitant medication was not provided. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. In May 2021 09:00 patient experienced Trunk rash (around 30 itchy red spots), Muscle aches (mostly hips and legs), Worsening eczema and itchiness on hands, Petechiae on shins. The patient was not taking any treatment. The outcome of all event was not recovered.
Moderna COVID-19 vaccine administered outside of company's standing order protocol(patient received vaccine while pregnant) no symptoms or adverse events reported by patient